Alessandro Russo, Medical Oncologist and Assistant Professor at Humanitas Clinical Institute of Catania, shared a post on LinkedIn:
“Congrats to my friends Fabrizio Citarella and Giuseppe Bronte for leading this project evaluating the role of local ablative treatments for oncogene-addicted NSCLCs. A very hot topic after WCLC and ESMO 2025. Combinatorial approaches using all the weapons in our therapeutic armamentarium is essential for improving our patients’ outcomes.”
Title: To ablate or not to ablate? Outcomes of local ablative treatments (LAT) for oncogene addicted (OA) oligo-metastatic (OM) non-small cell lung cancer (NSCLC): A systematic review
Authors: Fabrizio Citarella, Cristina Fragale, Matteo Fiorenti, Maria Luisa Di Guglielmo, Noemi Mindicini, Alessio Cortellini, Alessandro Russo, Giuseppe Bronte
More posts featuring Alessandro Russo on OncoDaily.